Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,956 | -28,284 | -71,327 | -34,969 | -11,485 |
| Depreciation Amortization | 107 | 86 | 286 | 49 | 163 |
| Income taxes - deferred | 365 | 0 | 1,052 | -1,052 | 0 |
| Accounts payable and accrued liabilities | -289 | -21 | -69 | 641 | 500 |
| Other Working Capital | -4,127 | 2,945 | 3,179 | 96 | 2,555 |
| Other Operating Activity | -5,260 | -17,595 | 37,950 | 14,262 | -6,401 |
| Operating Cash Flow | $-48,160 | $-42,869 | $-28,929 | $-20,973 | $-14,668 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 3,911 | N/A | N/A |
| PPE Investments | -153 | -57 | -320 | N/A | -53 |
| Net Acquisitions | N/A | -2,415 | N/A | N/A | 168 |
| Other Investing Activity | 10,548 | -3,056 | -15,631 | -87 | -101 |
| Investing Cash Flow | $10,395 | $-5,528 | $-12,040 | $-87 | $14 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 500 | 500 |
| Debt Issued | 0 | 0 | 9,865 | N/A | 0 |
| Debt Repayment | -3,911 | -1,766 | N/A | N/A | -84 |
| Common Stock Issued | 47,756 | 26,026 | 46,084 | 42,200 | 18,780 |
| Common Stock Repurchased | N/A | N/A | N/A | -266 | N/A |
| Financing Cash Flow | $43,845 | $24,260 | $55,949 | $42,434 | $19,196 |
| Beginning Cash Position | 23,650 | 47,787 | 32,807 | 11,433 | 6,891 |
| End Cash Position | 29,730 | 23,650 | 47,787 | 32,807 | 11,433 |
| Net Cash Flow | $6,080 | $-24,137 | $14,980 | $21,374 | $4,542 |
| Free Cash Flow | |||||
| Operating Cash Flow | -48,160 | -42,869 | -28,929 | -20,973 | -14,668 |
| Capital Expenditure | -153 | -57 | -320 | N/A | -53 |
| Free Cash Flow | -48,313 | -42,926 | -29,249 | -20,973 | -14,721 |